NPLEx (National Precursor Log Exchange)

(JACKSON, Miss) – The Consumer Healthcare Products Association (CHPA) applauds Mississippi Representative Stacey Wilkes, Senator Hob Bryan, and Governor Tate Reeves for passing and signing legislation into law requiring all manufacturers of over-the-counter (OTC) medicines containing pseudoephedrine (PSE) to participate in supporting the costs and administration of the National Precursor Log Exchange (NPLEx) system – a real-time stop-sale technology that allows retailers to enforce PSE sales limits and assist law enforcement in preventing illegal PSE sales. This important step not only strengthens the NPLEx system overall, but it enhances its long-term viability in preventing illegal sales of medicines containing PSE in Mississippi.

In a major victory for consumer health, today Mississippi has repealed an 11-year-old law that banned over-the-counter (OTC) sales of certain medicines for colds and allergies containing the decongestant pseudoephedrine (PSE).

CHPA applauds the state of Georgia for becoming the thirty-third state to adopt the real-time, stop-sale technology called the National Precursor Log Exchange (NPLEx).

So far, 31 states have adopted real-time, stop-sale technology. The blocking technology monitors all nonprescription PSE purchases in real-time to prevent meth criminals from exceeding legal limits.